Based in Sunnyvale, CA, Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.

Type
Subsidiary
Parent Company
Danaher
HQ
Sunnyvale, US
Founded
1996
Cepheid was founded in 1996 and is headquartered in Sunnyvale, US

Cepheid Office Locations

Cepheid has an office in Sunnyvale
Sunnyvale, US (HQ)
904 Building 1 E Caribbean Dr

Cepheid Data and Metrics

Cepheid Summary

Founding Date

1996
Cepheid is a subsidiary of Danaher

Cepheid Financial Metrics

Cepheid's revenue was reported to be $538.6 m in FY, 2015 which is a 15% increase from the previous period.
USDFY, 2013FY, 2014FY, 2015

Revenue

401.3 m470.1 m538.6 m

Revenue growth, %

17%15%

Cost of goods sold

207.9 m229.3 m269.9 m

Gross profit

193.4 m240.8 m268.7 m

Gross profit Margin, %

48%51%50%

Operating expense total

209.4 m274.9 m299.6 m

EBIT

(16 m)(34.1 m)(30.9 m)

EBIT margin, %

(4%)(7%)(6%)

Interest expense

137 k12.6 m14.7 m

Interest income

45 k1.1 m1.9 m

Pre tax profit

(16.8 m)(47.6 m)(47.3 m)

Income tax expense

(1.1 m)(2.6 m)(1.3 m)

Net Income

(18 m)(50.1 m)(48.5 m)
USDFY, 2013FY, 2014FY, 2015

Cash

66.1 m96.7 m112.6 m

Inventories

13 m24.3 m18.5 m

Current Assets

244 m519.1 m556.5 m

PP&E

84.9 m115.8 m127.6 m

Goodwill

39.7 m39.7 m39.7 m

Total Assets

394.6 m793.6 m821.6 m

Accounts Payable

52.6 m50.4 m57.8 m

Current Liabilities

95.5 m137.8 m142.5 m

Additional Paid-in Capital

145.9 m225.5 m263.4 m

Retained Earnings

(243.6 m)(293.7 m)(342.2 m)

Total Equity

285.2 m354.2 m370 m

Financial Leverage

1.4 x2.2 x2.2 x
USDFY, 2013FY, 2014FY, 2015

Net Income

(18 m)(50.1 m)(48.5 m)

Accounts Receivable

(7 m)(17 m)2.3 m

Inventories

(5.3 m)(5.2 m)(387 k)

Accounts Payable

17.3 m

Cash From Operating Activities

15 m9.2 m31.1 m

Capital Expenditures

(47.5 m)(47 m)(37.7 m)

Cash From Investing Activities

(71 m)(325.7 m)(39.9 m)

Cash From Financing Activities

26.6 m349.2 m27.5 m

Interest Paid

109 k

Income Taxes Paid

632 k

Free Cash Flow

62.5 m56.2 m68.7 m

Cepheid Median Salaries

Source: 30 public H-1B filings from Cepheid

Traffic Overview of Cepheid

Cepheid Online and Social Media Presence

Cepheid News and Updates

Research Company Danaher Is Buying Cepheid for $4 Billion

To strengthen its diagnostics business.

Cepheid Company Life and Culture

You may also be interested in